EFFECTIVENESS AND SAFETY OF SWITCHING TO TENOFOVIR ALAFENAMIDE FUMARATE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B VIRUS INFECTED PATIENTS WITH OSTEOPOROSIS RISK: 24 WEEKS AND 48weeks RESULTS OF A REAL-WORLD STUDY
HEPATOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要